Fatty liver with metabolic disorder, such as metabolic dysfunction‐associated fatty liver disease, indicates high risk for developing diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fatty liver with metabolic disorder, such as metabolic dysfunction‐associated fatty liver disease, indicates high risk for developing diabetes mellitus

Published:2022-02-28 Issue:7 Volume:13 Page:1245-1252
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J of Diabetes Invest

Author:

Miyake Teruki¹^ORCID,Matsuura Bunzo²,Furukawa Shinya³,Ishihara Toru⁴,Yoshida Osamu¹,Miyazaki Masumi¹,Watanebe Kyoko¹,Shiomi Akihito¹,Nakaguchi Hironobu²,Yamamoto Yasunori¹,Koizumi Yohei¹,Tokumoto Yoshio¹,Hirooka Masashi¹,Takeshita Eiji¹,Kumagi Teru⁵,Abe Masanori¹,Ikeda Yoshio¹,Iwata Takeru⁴,Hiasa Yoichi¹^ORCID

Affiliation:

1. Department of Gastroenterology and Metabology Ehime University Graduate School of Medicine Toon Japan

2. Department of Lifestyle‐Related Medicine and Endocrinology Ehime University Graduate School of Medicine Toon Japan

3. Health Services Center Ehime University Matsuyama Japan

4. Ehime General Health Care Association Matsuyama Japan

5. Postgraduate Medical Education Center Ehime University Graduate School of Medicine Toon Japan

Funder

Japan Society for the Promotion of Science London

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13772

Reference23 articles.

1. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research

2. Significantly Increased Risk of Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis

3. Diabetes mellitus and cancer risk: Pooled analysis of eight cohort studies in Japan

4. Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients

5. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period;Hepatology Research;2024-08-07

2. Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis;Journal of Gastroenterology and Hepatology;2024-04-17

3. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis;BMC Medicine;2024-03-06

4. The mediation role of blood lipids on the path from air pollution exposure to MAFLD: A longitudinal cohort study;Science of The Total Environment;2023-12

5. Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD;Scientific Reports;2023-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3